Overview The Safety, Tolerability, and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy Subjects Status: Completed Trial end date: 2019-12-06 Target enrollment: Participant gender: Summary The Safety, Tolerability and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy Male and Female Subjects Phase: Phase 1 Details Lead Sponsor: Sunshine Lake Pharma Co., Ltd.